Form 4 for VKTX Viking Therapeutics, Inc.
Accepted 2023-04-13 00:00:00 ET · period of report 2023-04-13 · accession 0001209191-23-024228 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-13 | 2023-04-13 | VKTX | Lian Brian | Pres, CEO, Dir | S - Sale+OE | $18.45 | -79.3K | 2.31M | -3% | -$1.46M |
| D | 2023-04-13 | 2023-04-13 | VKTX | Lian Brian | Pres, CEO, Dir | M - OptEx | $1.88 | +54.3K | 2.39M | +2% | +$102.2K |
| D | 2023-04-13 | 2023-04-13 | VKTX | Lian Brian | Pres, CEO, Dir | M - OptEx | $0.00 | -54.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.00001 per share | 2023-04-13 | S | D | 79,336 | $18.45 | 2,307,963 | D | — | — | |
| 2 | Common | Common Stock, par value $0.00001 per share | 2023-04-13 | M | A | 54,336 | $1.88 | 2,387,299 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2023-04-13 | M | D | 54,336 | $0.00 | 0 | D | $1.88 · 2016-03-14 to 2026-03-14 | 54,336 Common Stock |